Cargando…

Safety and immunogenicity of MVC-COV1901 vaccine in older adults: Phase 2 randomized dose-comparison trial

INTRODUCTION: Older adults are subject to higher COVID-19 infection and mortality rates. Safety and immunogenicity of MVC-COV1901, a protein subunit vaccine have been demonstrated in phase 2 clinical trial for the general population, and negative correlations have been observed between immune respon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Waits, Alexander, Chen, Jau-Yuan, Cheng, Wei-Hong, Yeh, Jih-I, Hsieh, Szu-Min, Chen, Charles, Janssen, Robert, Lien, Chia En, Lin, Tzou-Yien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422336/ https://www.ncbi.nlm.nih.gov/pubmed/36049700 http://dx.doi.org/10.1016/j.ijid.2022.08.021

Ejemplares similares

A Retrospective Study of the Safety and Immunogenicity of MVC-COV1901 Vaccine for People Living with HIV
por: Cheng, Shu-Hsing, et al.
Publicado: (2022)

Immunogenicity and safety of heterologous mRNA-1273/MVC-COV1901 vaccination versus homologous mRNA1273 vaccination: A randomized, double-blind controlled study
por: Huang, Szu-Ting, et al.
Publicado: (2023)

Safety and immunogenicity of homologous versus heterologous booster dose with AZD1222, mRNA-1273, or MVC-COV1901 SARS-CoV-2 vaccines in adults: An observer-blinded, multi-center, phase 2 randomized trial
por: Estephan, Lila, et al.
Publicado: (2023)

Durability and Immunogenicity of Neutralizing Antibodies Response Against Omicron Variants After Three Doses of Subunit SARS-CoV-2 Vaccine MVC-COV1901: An Extension to an Open-Label, Dose-Escalation Phase 1 Study
por: Hsieh, Szu-Min, et al.
Publicado: (2022)

Safety and immunogenicity of SARS-CoV-2 vaccine MVC-COV1901 in Taiwanese adolescents: a randomized phase 2 trial
por: Liu, Luke Tzu-Chi, et al.
Publicado: (2022)

An evaluation of the safety and immunogenicity of MVC-COV1901: Results of an interim analysis of a phase III, parallel group, randomized, double-blind, active-controlled immunobridging study in Paraguay
por: Torales, Julio, et al.
Publicado: (2023)

Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan
por: Hsieh, Szu-Min, et al.
Publicado: (2021)

Safety and Immunogenicity of a Heterologous Booster of Protein Subunit Vaccine MVC-COV1901 after Two Doses of Adenoviral Vector Vaccine AZD1222
por: Cheng, Shu-Hsing, et al.
Publicado: (2022)

Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC—COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study
por: Hsieh, Szu-Min, et al.
Publicado: (2021)

Protection of hamsters challenged with SARS-CoV-2 after two doses of MVC-COV1901 vaccine followed by a single intranasal booster with nanoemulsion adjuvanted S-2P vaccine
por: Lin, Yi-Jiun, et al.
Publicado: (2022)

An Immunobridging Study to Evaluate the Neutralizing Antibody Titer in Adults Immunized with Two Doses of Either ChAdOx1-nCov-19 (AstraZeneca) or MVC-COV1901
por: Estrada, Josue Antonio, et al.
Publicado: (2022)

ASP.NET MVC in action: with MvcContrib, NHibernate, and more
por: Palermo, Jeffrey, et al.
Publicado: (2010)

Life after the MVC
por: Tzovanakis, Harris
Publicado: (2017)

Pro PHP MVC
por: Pitt, Chris
Publicado: (2012)

Boosting with Multiple Doses of mRNA Vaccine after Priming with Two Doses of Protein Subunit Vaccine MVC-COV1901 Elicited Robust Humoral and Cellular Immune Responses against Emerging SARS-CoV-2 Variants
por: Chiu, Chun-Hsiang, et al.
Publicado: (2022)

A randomized controlled trial of heterologous ChAdOx1 nCoV-19 and recombinant subunit vaccine MVC-COV1901 against COVID-19
por: Chen, Chih-Jung, et al.
Publicado: (2022)

Learn ASP.NET MVC
por: Weil, Arnaud
Publicado: (2015)

Professional ASPNET MVC 3
por: Galloway, Jon, et al.
Publicado: (2011)

Learning ASP.NET Core MVC programming: learn the fundamentals of ASP.NET MVC and build real-world web applications using ASP.NET Core MVC
por: Ragupathi, Mugilan T S
Publicado: (2016)

Professional ASP.NET MVC 5
por: Galloway, Jon, et al.
Publicado: (2014)

Beginning ASP.NET MVC 4
por: Guay Paz, José Rolando
Publicado: (2013)

Pro ASPNET MVC 2 Framework
por: Freeman, A, et al.
Publicado: (2010)

Professional ASP.NET MVC 2
por: Galloway, Jon, et al.
Publicado: (2010)

Pro ASP.NET Core MVC /
por: Freeman, Adam, 1972-
Publicado: (2016)

ASP.NET MVC 2 in action
por: Palermo, Jeffrey
Publicado: (2010)

Programming ASP.NET MVC 4
por: Chadwick, Jess, et al.
Publicado: (2012)

ASP.NET MVC 4 in action
por: Palermo, Jeffrey
Publicado: (2012)

Programming Microsoft ASP.NET MVC
por: Esposito, Dino
Publicado: (2011)

ASP.NET MVC framework unleashed
por: Walther, Stephen
Publicado: (2010)

Pro Spring MVC: with Web Flow
por: Deinum, Marten, et al.
Publicado: (2012)

Pro ASPNET MVC 3 Framework
por: Freeman, A, et al.
Publicado: (2011)

Professional ASP.NET MVC 4
por: Galloway, Jon
Publicado: (2012)

Mobile ASP.NET MVC 5
por: Sowell, Eric
Publicado: (2013)

Pro ASP.NET MVC 5
por: Freeman, Adam
Publicado: (2013)

Programming Microsoft ASP.NET MVC
por: Esposito, Dino
Publicado: (2014)

Pro ASP.NET MVC 4
por: Freeman, Adam
Publicado: (2013)

Methodological considerations in MVC epidemiological research
por: Fridman, Liraz, et al.
Publicado: (2021)

Spring MVC cookbook: over 40 recipes for creating cloud-ready Java web applications with Spring MVC
por: Bretet, Alex
Publicado: (2016)

Where in 1901?
Publicado: (1900)

Mastering Spring MVC 4: gain expertise in designing real-world web applications using the Spring MVC framework
por: Warin, Geoffroy
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hpfavcmv35g5htbocut2ft5e4a